Differential Effects of Drug-Eluting Stents on Local Endothelium-Dependent Coronary Vasomotion
Michalis I. Hamilos, MD*,
Miodrag Ostojic, MD, PhD ,
Branko Beleslin, MD, PhD,
Dragan Sagic, MD, PhD ,
Ljubco Mangovski, MD,
Sinisa Stojkovic, MD, PhD,
Milan Nedeljkovic, MD, PhD,
Dejan Orlic, MD,
Bratislav Milosavljevic, MD,
Dragan Topic, MD,
Nevena Karanovic, MD, PhD ,
William Wijns, MD, PhD*,* on behalf of the NOBORI CORE Investigators
* Cardiovascular Centre, Aalst, Belgium
Department of Cardiology, University Institute for Cardiovascular Diseases, Clinical Center of Serbia, Belgrade, Serbia
Institute for Cardiovascular Disease Dedinje, Belgrade, Serbia
Ministry of Health of Serbia, Belgrade, Serbia.
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Distribution of Diameter Changes in Patients With BES and SES
Scatterplots showing the distribution of percent mean diameter changes from baseline to maximal pacing rate in patients with biolimus A9-eluting stents (BES) and sirolimus-eluting stents (SES), in proximal (A) and distal (B) segments.
|
|
View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Mean Diameter of the Proximal, Distal, and Reference Segments in the BES and SES Groups
Mean diameter values at baseline, maximal pacing rate, and after nitroglycerin administration in BES and SES groups, in proximal (A), distal (B), and reference (A and B) segments. The p values for the comparison between BES and SES are indicated for both proximal and distal segments. Abbreviations as in Figure 1.
|
|
|
